Ami Organics, Vijaya Diagnostic make strong stock market debuts

Ami Organics' stock closed at Rs 935, with a gain of Rs 325, while Vijaya Diagnostic finished at Rs 619, with a gain of Rs 88.

Ashish Chauhan, MD&CEO, BSE India presenting a memento Shri Nareshkumar Ramjibhai Patel, Executive Chairman and MD, Ami Organics Limited and other senior officials at the listing ceremony
Ashish Chauhan, MD&CEO, BSE India presenting a memento Shri Nareshkumar Ramjibhai Patel, Executive Chairman and MD, Ami Organics Limited and other senior officials at the listing ceremony
Sundar Sethuraman Mumbai
2 min read Last Updated : Sep 15 2021 | 1:39 AM IST
Shares of Ami Organics and Vijaya Diagnostic rallied 53 per cent and 17 per cent over their issue price during their stock market debut on Tuesday.

Ami Organics’ stock closed at Rs 935, with a gain of Rs 325, while Vijaya Diagnostic finished at Rs 619, with a gain of Rs 88.

Ami Organics’ initial public offering (IPO) was subscribed 65 times. Its IPO consisted of Rs 200-crore fresh fund raise and Rs 370-crore secondary share sale.

Vijaya Diagnostic, one of the largest diagnostic chains in southern India, garnered 4.5 times subscription for its IPO. The IPO was entirely a secondary share sale worth Rs 1,894 crore.

The listing gains made by Ami Organics and Vijaya Diagnostic end the succession of tepid listings in the recent past. Shares of the previous four companies to make their stock market debut had dropped below their IPO price on listing day.

So far, till August 2021, companies have raised Rs 60,288 crore through IPOs, the highest since 2017.

Sansera Engineering IPO subscribed 53% on day1

Sansera Engineering’s IPO was subscribed 53 per cent on Tuesday, the first day of the issue. A day earlier, the auto component maker had allotted shares worth Rs 382 crore to anchor investors at Rs 744 per share. Sansera has priced its issue between Rs 734 and Rs 744 per share. Sansera’s IPO is entirely an offer for sale worth Rs 1,283 crore. At the top-end of the price band, the company’s market cap translates to Rs 3,823 crore. “At Rs 744, FY21 P/E of 35 times appears reasonable given the expected improvement in earnings CAGR over FY21-23 and hence we recommend subscribe,” AngelOne said in a note.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :stock marketlisting

Next Story